Literature DB >> 596218

Catecholamines and pancreatic hormones during autonomic blockade in exercising man.

H Galbo, N J Christensen, J J Holst.   

Abstract

The importance of autonomic nervous activity for the pancreatic hormonal response to exercise in man was studied. 7 men ran at 58% of V(O2)max (determined without administration of drugs) to exhaustion during alpha-adrenergic blockade with phentolamine (P), during parasympathetic blockade with atropine (A), or without drugs (C). At rest phentolamine increased the plasma concentrations of both insulin and norepinephrine. During exercise norepinephrine concentrations increased and were in P experiments 3 times the concentrations in C experiments. Insulin always declined during exercise but in P experiments never decreased below basal levels. At identical times neither glucagon nor glucose differed significantly in the different expts. Thus during exercise alpha-adrenergic blockade increased insulin concentrations but did not diminish the glucagon response. Nor was this response increased when beta-receptor stimulation in P experiments was intensified by the particularly high catecholamine concentrations. The concentrations of FFA, glycerol and lactate were highest in P experiments and identical in A and C experiments. These findings indicate that during prolonged moderate exercise in man insulin secretion is depressed by stimulation of alpha-adrenergic receptors whereas glucagon secretion is not influenced by adrenergic receptors. Stimulation of beta-adrenergic receptors enhances lipolysis but neither lipolysis nor pancreatic hormonal secretion is influenced by cholinergic activity during exercise.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596218     DOI: 10.1111/j.1748-1716.1977.tb06026.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  16 in total

1.  Effects of alpha-adrenoceptor and of combined sympathetic and parasympathetic blockade on cardiac performance and vascular resistance.

Authors:  H Kelbaek; H Frandsen; J Hilsted; N J Christensen; S L Nielsen
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.

Authors:  N J Christensen; J Trap-Jensen; T L Svendsen; S Rasmussen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

Review 3.  Catecholamines and diabetes mellitus.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

Review 4.  Hormonal alterations due to exercise.

Authors:  J C Bunt
Journal:  Sports Med       Date:  1986 Sep-Oct       Impact factor: 11.136

5.  Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.

Authors:  H J Kornerup; E B Pedersen; N J Christensen; A Pedersen; G Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

6.  The role of the adrenergic innervation to the pancreatic islets in the control of insulin release during exercise in man.

Authors:  J Järhult; J Holst
Journal:  Pflugers Arch       Date:  1979-12       Impact factor: 3.657

7.  Influence of the sympatho-adrenal system and somatostatin on the secretion of insulin in the rat.

Authors:  B Ahrén; J Järhult; I Lundquist
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

8.  Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.

Authors:  D C Simonson; V Koivisto; R S Sherwin; E Ferrannini; R Hendler; A Juhlin-Dannfelt; R A DeFronzo
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.

Authors:  D H Wasserman; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.

Authors:  D R Hoelzer; G P Dalsky; W E Clutter; S D Shah; J O Holloszy; P E Cryer
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.